Doctor-modified stent graft for complex aortic aneurysms in the abdomen and chest
Tests a doctor-modified stent graft for complex aortic aneurysms in high-risk adults.
Key facts
- Who runs it
- University of California, Davis
- Where
- San Diego, United StatesSee the site
- Trial code
- Registry title
- Physician Modified Endograft For Complex Aortic Aneurysm Repair
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 1 Mar 2023
- Expected to end
- Dec 2029
- Type of study
- Interventional
- Treatments tested
- Endovascular Treatment of Complex abdominal or Thorocoabdominal aneurysms (TAAA).
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a complex aortic aneurysm near the kidney or gut arteries, or in the chest and belly. They must be at high risk for open surgery and unable to be treated with an approved stent graft.
- Age
- Over 18 years.
- Sex
- Men and women who are not pregnant. Women who could become pregnant need a negative pregnancy test before joining.
- Disease stage
- Complex, juxtarenal, pararenal or thoracoabdominal aortic aneurysm (Extent I-V). It must be at least 5.5cm (2.2 in) wide, or have grown at least 0.5cm (0.2 in) in the last 6 months, or be causing symptoms. The neck of the aorta above the aneurysm must be at least 20 mm long and between 15 and 42mm wide. The pelvic (iliac) artery landing area must be at least 15 mm long and between 7 and 20 mm wide.
- Earlier treatment
- High risk for open surgery can come from past belly surgery, past left-sided chest surgery, past aortic surgery, or from health factors such as heart disease, heart failure, COPD, age over 70 years, or ASA Category III or higher.
Main reasons for not taking part
- Infected (mycotic) aneurysm, or a burst aneurysm needing urgent repair.
- An infection that could raise the risk of the graft getting infected.
- Allergy to blood thinners or contrast dye that cannot be treated first, or to stainless steel, polyester, polypropylene, nickel, titanium or gold.
- Connective tissue disease such as Marfan's or Ehler's-Danlos syndrome, or unstable angina.
- Expected to live less than 2 years, including from active cancer.
The registry criteria, word for word
Show all 33 criteriaShow less
Other criteria
- ---Inclusion criteria---
- Patient is > 18 years of age
- Patients who are male or non-pregnant female (females of child bearing potential must have a negative pregnancy test prior to enrollment into the study)
- Patient is able and willing to sign an Institutional Review Board (IRB) approved Informed Consent Form
- Patient has a complex, juxtarenal, pararenal or thoracoabdominal abdominal aortic aneurysm (Extent I-V) that meets at least one of the following:; Aortic aneurysm with diameter ≥ 5.5cm; Aortic aneurysm with a history of growth ≥0.5cm in the last 6 months; Symptomatic aortic aneurysm
- Cannot be treated with a currently available non-modified approved device
- High risk for open surgical repair based on any of the factors below:; Anatomic i. Previous abdominal surgery ii. Previous left-sided thoracotomy (if the proposed open repair would require dissection of the thoracic aorta) iii. Previous aortic surgery; Physiologic i. ASA Category III or higher ii. Age >70 years iii. Previous myocardial infarction, coronary artery disease, or coronary artery stent iv. Coronary stress test with a reversible perfusion defect v. Congestive heart failure vi. COPD
- Patient has patent iliac or femoral arteries that will allow endovascular access with the physician modified endovascular graft or is suitable for an iliac conduit
- Patient has a suitable non-aneurysmal proximal aortic neck length (seal zone) of ≥ 20 mm
- Patient has a suitable non-aneurysmal distal iliac artery length (seal zone) of ≥ 15 mm
- The resultant repair should preserve patency in at least one hypogastric artery
- Patient has a suitable non-aneurysmal proximal aortic neck diameter between 15 and 42mm
- Patient has suitable non-aneurysmal distal common iliac diameters between 7 and 20 mm; ---Exclusion Criteria---; -General Exclusion Criteria-
- Patient has a mycotic aneurysm
- Patient has a ruptured aneurysm requiring urgent or emergent repair
- Patient has a systemic or local infection that may increase the risk of graft infection
- Patient has a body habitus that would inhibit X-ray visualization of the aorta
- Patient is willing and eligible to participate in a manufacturer-sponsored clinical study at another institution
- Patient has a major surgical or interventional procedure planned within +/- 30 days of the (T)AAA repair
- Patient is currently participating in another investigational device or drug clinical trial; -Medical Exclusion Criteria-
- Patient has a known hypersensitivity or contraindication to anticoagulation or contrast media that is not amenable to pre-treatment
- Patient has a known allergy or intolerance to stainless steel, polyester, polypropylene, nickel, titanium or gold
- Patient has uncorrectable coagulopathy
- Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
- Patient has history of connective tissue disease (e.g., Marfan's or Ehler's-Danlos syndrome)
- Patient has active malignancy with life expectancy of less than 2 years
- Patient has a limited life expectancy of less than 2 years
- Patient has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations; -Anatomic Exclusion Criteria-
- Significant occlusive disease, tortuosity or calcification that would prevent endovascular access
- Proximal seal site with a circumferential thrombus/atheroma
- Inability to maintain at least one patent hypogastric artery
- Shaggy aorta
- Patient is not amenable to a temporary or permanent open surgical or endovascular conduit
Where in United States
- University of California San DiegoSan Diego, United StatesContact: Andrew Barleben, MD, MPHTaking people
About the trial
What the trial wants to find out
The physician modified endograft is intended for treating complex, pararenal, juxtarenal and thoracoabdominal aortic aneurysms requiring coverage of renal arteries, the superior mesenteric artery or the celiac trunk in high-risk patients who do not have an option for endovascular repair with an FDA approved endograft and have an appropriate anatomy. There will be one investigational site with a total of 40 subjects to be enrolled. Time to complete enrollment will be 24 months and the subject follow-up time will be five years from last subject enrollment.
Read full original descriptionShow less
The primary safety endpoint is freedom from major adverse events (MAE) at 30 days or during hospitalization if this exceeds 30 days. The primary effectiveness endpoint is the proportion of study subjects with treatment success at one year. The subjects will be followed at one month, six months, one year, and yearly thereafter for a total period of five years. Subjects will be followed up clinically for life. Clinical exam follow up may be phone or video visit with CT scan evaluation and duplex ultrasound as needed. The proportion of treatment group subjects that achieve and maintain treatment success annually to five years will be investigated.
The group in the trial
- Physician-Modified EndograftTreatment being tested
This is a single arm study used to evaluate the safety and effectiveness of fenestrated and branched techniques for the treatment of patients with a complex, juxtarenal, pararenal or thoracoabdominal abdominal aortic aneurysms (Extent I-V).
Treatment: Endovascular Treatment of Complex abdominal or Thorocoabdominal aneurysms (TAAA).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Single-Arm, Single-Center, Non-Randomized, Prospective Clinical Study to Evaluate the Safety and Effectiveness of Physician Modified Endograft for Complex Abdominal and Thoracoabdominal Aortic Aneurysm Repair
- Plain-language title
- Doctor-modified stent graft for complex aortic aneurysms in the abdomen and chestGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 6 May 2026